Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis.
Changhoon Yoo, Sang Soo Lee, Ki Byung Song, Jae Ho Jeong, Jaewon Hyung, Do Hyun Park, Tae Jun Song, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Seung Soo Lee, Jin Hee Kim, Hyung-Seung Jin, Jin-Hong Park, Dae Wook Hwang, Jae Hoon Lee, Woohyung Lee, Heung-Moon Chang, Kyu-Pyo Kim, Baek-Yeol Ryoo, Song Cheol Kim
British journal of cancer 2021;123(3):362-368